Page last updated: 2024-09-03

reboxetine and Briquet Syndrome

reboxetine has been researched along with Briquet Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aragona, M; Bancheri, L; Conte, A; Inghilleri, M; Perinelli, D; Pizzimenti, A; Tarsitani, L	1

Trials

1 trial(s) available for reboxetine and Briquet Syndrome

Article	Year
Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. European journal of pain (London, England), 2005, Volume: 9, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Analgesics; Central Nervous System; Citalopram; Depressive Disorder; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Pain Measurement; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Somatoform Disorders; Treatment Outcome	2005

Article

Year

Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.

European journal of pain (London, England), 2005, Volume: 9, Issue:1

Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Analgesics; Central Nervous System; Citalopram; Depressive Disorder; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Pain Measurement; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Somatoform Disorders; Treatment Outcome

2005